Functional characterization of an isogenic meningococcal α 2,3 sialyltransferase mutant: The role of lipooligosaccharide sialylation for serum resistance in serogroup B meningococci

Medical Microbiology and Immunology

Volumn 186, Issue 2-3, 1997, Pages 159-166

  Vogel, Ulrich ^a   Claus, Heike ^a   Heinze, Gabriele ^a   Frosch, Matthias ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

2,3 sialyltransferase lst gene; Infant rat; Meningococci; Serum resistance

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; COMPLEMENT COMPONENT C3B; EPITOPE; IMMUNOGLOBULIN M; MUTANT PROTEIN; OLIGOSACCHARIDE; SIALIC ACID; SIALYLTRANSFERASE;

ARTICLE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; CONTROLLED STUDY; HUMAN; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SERUM BACTERICIDAL ACTIVITY; SIALYLATION;

ANIMALS; BLOOD BACTERICIDAL ACTIVITY; CARBOHYDRATE SEQUENCE; COMPLEMENT C3; DISEASE MODELS, ANIMAL; GENES, BACTERIAL; HUMANS; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDES; MENINGOCOCCAL INFECTIONS; MOLECULAR SEQUENCE DATA; MUTATION; NEISSERIA MENINGITIDIS; PHENOTYPE; RATS; SEROTYPING; SIALYLTRANSFERASES;

EID: 0030668781     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004300050059     Document Type: Article

References (46)

1. Apicella MA, Griffiss JM, Schneider H (1994) Isolation and characterization of lipopolysaccharides, lipooligosaccharides, and lipid A. Methods Enzymol 235:242-252
2. Campbell JR, Baker CJ, Edwards MS (1991) Deposition and degradation of C3 on type III group B streptococci. Infect Immun 59:1978-1983
3. Croize J, Arvieux J, Berche P, Colomb MG (1993) Activation of the human complement alternative pathway by Listeria monocytogenes: evidence for direct binding and proteolysis of the C3 component on bacteria. Infect Immun 61:5134-5139
4. De la Paz H, Cooke SJ, Heckels JE (1995) Effect of sialylation of lipopolysaccharide of Neisseria gonorrhoeae on recognition and complement-mediated killing by monoclonal antibodies directed against different outer-membrane antigens. Microbiology 141:913-920
5. Elkins C, Carbonetti NH, Varela VA, Stirewalt D, Klapper DG, Sparling PF (1992) Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated. Mol Microbiol 6:2617-2628
6. Estabrook MM, Baker CJ, Griffiss JM (1993) The immune response of children to menigococcal lipooligosaccharides during disseminated disease is directed primarily against two monoclonal antibody-defined epitopes. J Infest Dis 167:966-970
7. Ferrieri P, Burke B, Nelson J (1980) Production of bacteremia and meningitis in infant rats with group B streptococcal sero-types. Infect Immun 27:1023-1032
8. Fitzgerald TJ (1987) Activation of the classical and alternative pathways of complement by Treponema pallidum subsp. pallidum and Treponema vincentii. Infect Immun 55:2066-2073
9. Frangipane JV, Rest RF (1993) Anaerobic growth and cytidine 5′-monophospho-N-acetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae. Infect Immun 61:1657-1666
10. Frosch M, Weisgerber C, Meyer TF (1989) Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B, Proc Natl Acad Sci USA 86:1669-1673
11. Frosch M, Sehultz E, Glenn Calvo E, Meyer TF (1990) Generation of capsule-deficient Neisseiria meningitidis strains by homologous recombination. Mol Microbiol 4:1215-1218
12. Gilbert M, Watson DC, Cunningham AM, Jennings MP, Young NM, Wakarchuk WW (1996) Cloning of the lipooligosaccharide α-2,3-sialyltransferase from the bacterial pathogens Neisseria meningitidis and Neisseria gonorrhoeae. J Biol Chem 271:28271-28276
13. Gill MJ, McQuillen DP, Putten JP van. et al (1996) Functional characterization of a sialyltransferase-deficient mutatn of Neisseria gonorrhoeae. Infect Immun 64:3374-3378
14. Grossman N, Joiner KA, Frank MM, Leive L (1986) C3b binding, but not its breakdown, is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from Salmonellae. J Immunol 136:2208-2215
15. Hammerschmidt S, Birkholz C, Zähringer U, et al (1994) Contribution of genes from the capsule gene complex (eps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. Mol Microbiol 11:885-896
16. Hammerschmidt S, Hilse R, Putten JP van, Gerardy Schahn R, Unkmeir A, Frosch M (1996) Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J 15:192-198
17. Hong K, Kinoshita, Takeda J, et al. (1990) Inhibition of the alter-native C3 convertase and classical C5 convertase of complement by group A streptococcal M protein. Infect Immun 58:2535-2541
18. Horstmann RD (1992) Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation. Infect Immun 60:771-727
19. Horstmann RD, Sievertsen HJ, Knobloch J, Fischetti VA (1988) Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci USA 85:1657-1661
20. Jennings MP, Hood DW, Peak IR, Virji M, Moxon ER (1995) Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis. Mol Microbiol 18:729-740
21. Joiner KA (1988) Complement evasion by bacteria and parasites. Annu Rev Microbiol 42:201-230
22. Joiner KA, Hammer CH, Brown EJ, Cole RJ, Frank MM (1982) Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death. J Exp Med 155:797-808
23. Joiner KA, Hammer CH, Brown EJ, Frank MM (1982) Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella Minnesota S218 because the terminal complex does not insert into the bacterial outer membrane. J Exp Med 155:809-819
24. Joiner KA, Warren KA, Hammer C, Frank MM (1985) Bactericidal but not nonbactericidal C5b-9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae. J Immunol 134:1920-1925
25. Kim JJ, Zhou D, Mandrell RE, Griffiss JM (1992) Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis. Infect Immun 60:4439-4442
26. Klein NJ, Ison CA, Peakman M, et al (1996) The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis. J Infect Dis 173:172-179
27. Klos A, Ihrig V, Messner M, Grabbe J, Bitter Suermann D (1988) Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies. J Immunol Methods 111:241-252
28. Kozel TR (1996) Activation of the complement system by pathogenic fungi. Clin Microbiol Rev 9:34-46
29. Lee FK, Stephens DS, Gibson BW, Engstrom JJ, Zhou D, Apicella MA (1995) Microheterogeneity of Neisseria lipooligosaccharide: analysis of a UDP-glucose 4-epimerase of Neisseria meningitidis NMB. Infect Immun 63:2508-2515
30. Mandrell RE, Apicella MA (1993) Lipooligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. Immunobiology 187:382-402
31. Mandrell RE, Griffiss JM, Smith H, Cole JA (1993) Distribution of a lipooligosaccharide-specific sialyltransferase in pathogenic and non-pathogenic Neisseria. Microb Pathog 14:315-327
32. Marques MB, Kasper DL, Pangburn MK, Wessels MR (1992) Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect Immun 60:3986-3993
33. Moran EE, Brandt BL, Zollinger WD (1994) Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity. Infect Immun 62:5290-5295
34. Norris KA, Schrimpf JE, Szabo MJ (1997) Identification of the gene family encoding the 160-kilodalton Trypanosoma cruzi complement regulatory protein. Infect Immun 65:349-357
35. Parsons NJ, Andrade JR, Patel PV, Cole JA, Smith H (1989) Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5′-monophospho-N-acetyl neuraminic acid. Microb Pathog 7:63-72
36. Pilatte Y, Bignon J, Lambre CR (1993) Sialic acids as important molecules in the regulation of the immune system: pathophysiological implications of sialidases in immunity. Glycobiology 3:201-218
37. Rest RF, Frangipane JV (1992) Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils. Infect Immun 60:989-997
38. Sambrook J, Fritsch EF, Maniatis T (eds) (1989) Molecular cloning. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
39. Sturtevant JE, Latge JP (1992) Interactions between conidia of Aspergillus fumigatus and human complement component C3. Infect Immun 60:1913-1918
40. Swartley JS, Marfin AA, Edupuganti S, et al (1997) Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci USA 94:271-276
41. Toney DM, Marciano Cabral F (1994) Membrane vesiculation of Naegleria fowleri amoebae as mechanism for resisting complement damage. J Immunol 152:2952-2959
42. Vogel U, Hammerschmidt S, Frosch M (1996) Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitidis serogroup B are prerequisites for virulence of meningococci in the infant rat model. Med Microbiol Immunol 185:81-87
43. Vogel U, Steinmetz I, Frosch M (1996) Avoiding artifacts in the infant rat model for bacterial meningitis: use of Sangur test strips for the rapid quantification of blood contamination in cerebrospinal fluid. Med Microbiol Immunol 185:27-30
44. Vogel U, Weinberger A, Frank R, Müller A, Kohl J, Atkinson JP, Frosch M (1997) Complement factor C3 deposition and serum resistance in isogenic capsule and LOS sialic acid mutants of serogroup B Neisseria meningitidis. Infect Immun (in press)
45. Ward CK, Inzana TJ (1994) Resistance of Actinobacillus pleuropneumoniae to bactericidal antibody and complements is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide. J Immunol 153:2110-2121
46. Wetzler LM, Barry K, Blake MS, Gotschlich EC (1992) Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera. Infect Immun 60:39-43